nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Redness of face—Capecitabine—colon cancer	0.0552	0.132	CcSEcCtD
Epinephrine—CYP2C9—Capecitabine—colon cancer	0.039	0.342	CbGbCtD
Epinephrine—Piloerection—Irinotecan—colon cancer	0.0286	0.0683	CcSEcCtD
Epinephrine—CYP1A2—Fluorouracil—colon cancer	0.0257	0.225	CbGbCtD
Epinephrine—PAH—gall bladder—colon cancer	0.0245	0.123	CbGeAlD
Epinephrine—CYP2C9—Fluorouracil—colon cancer	0.0231	0.203	CbGbCtD
Epinephrine—CYP3A4—Irinotecan—colon cancer	0.014	0.123	CbGbCtD
Epinephrine—Ischaemia—Irinotecan—colon cancer	0.0136	0.0325	CcSEcCtD
Epinephrine—CYP3A4—Vincristine—colon cancer	0.0123	0.107	CbGbCtD
Epinephrine—ADRBK1—embryo—colon cancer	0.0119	0.0596	CbGeAlD
Epinephrine—PAH—renal system—colon cancer	0.0118	0.0591	CbGeAlD
Epinephrine—TNF—vagina—colon cancer	0.0113	0.0569	CbGeAlD
Epinephrine—ADRBK1—smooth muscle tissue—colon cancer	0.00934	0.0468	CbGeAlD
Epinephrine—Cerebral haemorrhage—Vincristine—colon cancer	0.00921	0.022	CcSEcCtD
Epinephrine—ADRBK1—renal system—colon cancer	0.00899	0.0451	CbGeAlD
Epinephrine—Local reaction—Fluorouracil—colon cancer	0.00859	0.0205	CcSEcCtD
Epinephrine—Rales—Capecitabine—colon cancer	0.0081	0.0193	CcSEcCtD
Epinephrine—ADRBK1—lymphoid tissue—colon cancer	0.00747	0.0374	CbGeAlD
Epinephrine—ADRBK1—digestive system—colon cancer	0.00738	0.037	CbGeAlD
Epinephrine—TNF—lymph node—colon cancer	0.00733	0.0368	CbGeAlD
Epinephrine—PAH—liver—colon cancer	0.0072	0.0361	CbGeAlD
Epinephrine—Skin necrosis—Methotrexate—colon cancer	0.00708	0.0169	CcSEcCtD
Epinephrine—Peripheral coldness—Capecitabine—colon cancer	0.00698	0.0166	CcSEcCtD
Epinephrine—ADRBK1—bone marrow—colon cancer	0.0068	0.0341	CbGeAlD
Epinephrine—ADRBK1—vagina—colon cancer	0.00651	0.0327	CbGeAlD
Epinephrine—Myocardial ischaemia—Irinotecan—colon cancer	0.00618	0.0147	CcSEcCtD
Epinephrine—Necrosis—Fluorouracil—colon cancer	0.00606	0.0144	CcSEcCtD
Epinephrine—Rales—Methotrexate—colon cancer	0.00603	0.0144	CcSEcCtD
Epinephrine—Tingling sensation—Fluorouracil—colon cancer	0.00592	0.0141	CcSEcCtD
Epinephrine—Myocardial ischaemia—Fluorouracil—colon cancer	0.00592	0.0141	CcSEcCtD
Epinephrine—Extravasation—Vincristine—colon cancer	0.00584	0.0139	CcSEcCtD
Epinephrine—Extravasation—Irinotecan—colon cancer	0.00569	0.0136	CcSEcCtD
Epinephrine—ADRA1D—epithelium—colon cancer	0.00558	0.028	CbGeAlD
Epinephrine—SLC22A2—renal system—colon cancer	0.00553	0.0277	CbGeAlD
Epinephrine—Drug interaction—Vincristine—colon cancer	0.0055	0.0131	CcSEcCtD
Epinephrine—Extravasation—Fluorouracil—colon cancer	0.00545	0.013	CcSEcCtD
Epinephrine—ADRA1B—renal system—colon cancer	0.00529	0.0265	CbGeAlD
Epinephrine—Nephropathy—Methotrexate—colon cancer	0.0052	0.0124	CcSEcCtD
Epinephrine—Supraventricular tachycardia—Capecitabine—colon cancer	0.00507	0.0121	CcSEcCtD
Epinephrine—SLC22A2—digestive system—colon cancer	0.00454	0.0227	CbGeAlD
Epinephrine—Ventricular fibrillation—Capecitabine—colon cancer	0.00434	0.0103	CcSEcCtD
Epinephrine—Memory impairment—Capecitabine—colon cancer	0.00423	0.0101	CcSEcCtD
Epinephrine—ADRBK1—lymph node—colon cancer	0.00421	0.0211	CbGeAlD
Epinephrine—Tingling sensation—Capecitabine—colon cancer	0.00413	0.00986	CcSEcCtD
Epinephrine—Myocardial ischaemia—Capecitabine—colon cancer	0.00413	0.00986	CcSEcCtD
Epinephrine—SLC22A1—renal system—colon cancer	0.00391	0.0196	CbGeAlD
Epinephrine—Disorientation—Fluorouracil—colon cancer	0.00386	0.0092	CcSEcCtD
Epinephrine—Contusion—Capecitabine—colon cancer	0.00381	0.00908	CcSEcCtD
Epinephrine—Renal impairment—Irinotecan—colon cancer	0.00379	0.00903	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Capecitabine—colon cancer	0.00368	0.00877	CcSEcCtD
Epinephrine—Cerebrovascular accident—Irinotecan—colon cancer	0.00368	0.00877	CcSEcCtD
Epinephrine—Blood pressure increased—Capecitabine—colon cancer	0.00332	0.00793	CcSEcCtD
Epinephrine—Hypokalaemia—Irinotecan—colon cancer	0.00328	0.00782	CcSEcCtD
Epinephrine—ADRA1A—epithelium—colon cancer	0.00321	0.0161	CbGeAlD
Epinephrine—Skin exfoliation—Capecitabine—colon cancer	0.00317	0.00757	CcSEcCtD
Epinephrine—Necrosis—Methotrexate—colon cancer	0.00315	0.00752	CcSEcCtD
Epinephrine—Sweating increased—Irinotecan—colon cancer	0.00304	0.00724	CcSEcCtD
Epinephrine—ADRA1A—renal system—colon cancer	0.00297	0.0149	CbGeAlD
Epinephrine—Extravasation—Methotrexate—colon cancer	0.00284	0.00676	CcSEcCtD
Epinephrine—ADRA2C—renal system—colon cancer	0.00283	0.0142	CbGeAlD
Epinephrine—SLC22A1—vagina—colon cancer	0.00283	0.0142	CbGeAlD
Epinephrine—Acute coronary syndrome—Vincristine—colon cancer	0.00281	0.0067	CcSEcCtD
Epinephrine—Myocardial infarction—Vincristine—colon cancer	0.0028	0.00667	CcSEcCtD
Epinephrine—Acute coronary syndrome—Irinotecan—colon cancer	0.00274	0.00653	CcSEcCtD
Epinephrine—Sweating—Vincristine—colon cancer	0.00273	0.00652	CcSEcCtD
Epinephrine—Renal failure—Irinotecan—colon cancer	0.00273	0.00651	CcSEcCtD
Epinephrine—Myocardial infarction—Irinotecan—colon cancer	0.00272	0.00649	CcSEcCtD
Epinephrine—SLC22A5—renal system—colon cancer	0.00271	0.0136	CbGeAlD
Epinephrine—Sweating—Irinotecan—colon cancer	0.00266	0.00635	CcSEcCtD
Epinephrine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00262	0.00625	CcSEcCtD
Epinephrine—Myocardial infarction—Fluorouracil—colon cancer	0.00261	0.00622	CcSEcCtD
Epinephrine—Hypoaesthesia—Vincristine—colon cancer	0.00255	0.00608	CcSEcCtD
Epinephrine—Hallucination—Vincristine—colon cancer	0.00255	0.00608	CcSEcCtD
Epinephrine—Renal impairment—Capecitabine—colon cancer	0.00254	0.00604	CcSEcCtD
Epinephrine—Haemoglobin—Irinotecan—colon cancer	0.00251	0.00598	CcSEcCtD
Epinephrine—Haemorrhage—Irinotecan—colon cancer	0.00249	0.00595	CcSEcCtD
Epinephrine—ADRA1A—lymphoid tissue—colon cancer	0.00247	0.0124	CbGeAlD
Epinephrine—Cerebrovascular accident—Capecitabine—colon cancer	0.00246	0.00587	CcSEcCtD
Epinephrine—CYP1A2—renal system—colon cancer	0.00246	0.0123	CbGeAlD
Epinephrine—Haemoglobin—Fluorouracil—colon cancer	0.0024	0.00572	CcSEcCtD
Epinephrine—Haemorrhage—Fluorouracil—colon cancer	0.00239	0.0057	CcSEcCtD
Epinephrine—SLC22A1—liver—colon cancer	0.00239	0.012	CbGeAlD
Epinephrine—Hypoaesthesia—Fluorouracil—colon cancer	0.00238	0.00567	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—colon cancer	0.00236	0.00563	CcSEcCtD
Epinephrine—Flushing—Irinotecan—colon cancer	0.00231	0.00552	CcSEcCtD
Epinephrine—Mental disorder—Vincristine—colon cancer	0.00224	0.00535	CcSEcCtD
Epinephrine—Arrhythmia—Irinotecan—colon cancer	0.00223	0.00531	CcSEcCtD
Epinephrine—SLC22A5—digestive system—colon cancer	0.00223	0.0112	CbGeAlD
Epinephrine—Pulmonary oedema—Methotrexate—colon cancer	0.0022	0.00525	CcSEcCtD
Epinephrine—Hypokalaemia—Capecitabine—colon cancer	0.0022	0.00524	CcSEcCtD
Epinephrine—Arrhythmia—Fluorouracil—colon cancer	0.00213	0.00509	CcSEcCtD
Epinephrine—Erythema—Fluorouracil—colon cancer	0.00208	0.00496	CcSEcCtD
Epinephrine—ADRA2C—vagina—colon cancer	0.00205	0.0103	CbGeAlD
Epinephrine—Agitation—Vincristine—colon cancer	0.00205	0.00488	CcSEcCtD
Epinephrine—Sweating increased—Capecitabine—colon cancer	0.00203	0.00484	CcSEcCtD
Epinephrine—CYP1A2—digestive system—colon cancer	0.00202	0.0101	CbGeAlD
Epinephrine—SLC22A5—vagina—colon cancer	0.00197	0.00986	CbGeAlD
Epinephrine—Hypertension—Vincristine—colon cancer	0.00192	0.00459	CcSEcCtD
Epinephrine—CYP2C9—digestive system—colon cancer	0.00191	0.0096	CbGeAlD
Epinephrine—Hyperglycaemia—Capecitabine—colon cancer	0.00188	0.00449	CcSEcCtD
Epinephrine—Hypertension—Irinotecan—colon cancer	0.00187	0.00447	CcSEcCtD
Epinephrine—Acute coronary syndrome—Capecitabine—colon cancer	0.00183	0.00437	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—colon cancer	0.00183	0.00437	CcSEcCtD
Epinephrine—Renal failure—Capecitabine—colon cancer	0.00183	0.00436	CcSEcCtD
Epinephrine—Myocardial infarction—Capecitabine—colon cancer	0.00182	0.00435	CcSEcCtD
Epinephrine—ADRA1A—liver—colon cancer	0.00182	0.00911	CbGeAlD
Epinephrine—Nervous system disorder—Vincristine—colon cancer	0.00178	0.00425	CcSEcCtD
Epinephrine—CYP3A4—renal system—colon cancer	0.00178	0.00893	CbGeAlD
Epinephrine—Chest pain—Fluorouracil—colon cancer	0.00177	0.00422	CcSEcCtD
Epinephrine—Hyperhidrosis—Vincristine—colon cancer	0.00176	0.00419	CcSEcCtD
Epinephrine—Nervous system disorder—Irinotecan—colon cancer	0.00174	0.00414	CcSEcCtD
Epinephrine—ADRA2C—liver—colon cancer	0.00173	0.00868	CbGeAlD
Epinephrine—Hyperhidrosis—Irinotecan—colon cancer	0.00171	0.00408	CcSEcCtD
Epinephrine—Haemoglobin—Capecitabine—colon cancer	0.00168	0.004	CcSEcCtD
Epinephrine—Haemorrhage—Capecitabine—colon cancer	0.00167	0.00398	CcSEcCtD
Epinephrine—Nervous system disorder—Fluorouracil—colon cancer	0.00166	0.00397	CcSEcCtD
Epinephrine—Hypoaesthesia—Capecitabine—colon cancer	0.00166	0.00396	CcSEcCtD
Epinephrine—SLC22A5—liver—colon cancer	0.00166	0.00832	CbGeAlD
Epinephrine—Tachycardia—Fluorouracil—colon cancer	0.00166	0.00395	CcSEcCtD
Epinephrine—Insomnia—Vincristine—colon cancer	0.00165	0.00392	CcSEcCtD
Epinephrine—ADRA2A—vagina—colon cancer	0.00164	0.00821	CbGeAlD
Epinephrine—Paraesthesia—Vincristine—colon cancer	0.00163	0.0039	CcSEcCtD
Epinephrine—Insomnia—Irinotecan—colon cancer	0.0016	0.00382	CcSEcCtD
Epinephrine—Paraesthesia—Irinotecan—colon cancer	0.00159	0.00379	CcSEcCtD
Epinephrine—Somnolence—Irinotecan—colon cancer	0.00158	0.00376	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vincristine—colon cancer	0.00157	0.00375	CcSEcCtD
Epinephrine—Flushing—Capecitabine—colon cancer	0.00155	0.00369	CcSEcCtD
Epinephrine—Insomnia—Fluorouracil—colon cancer	0.00153	0.00366	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00153	0.00365	CcSEcCtD
Epinephrine—Paraesthesia—Fluorouracil—colon cancer	0.00152	0.00363	CcSEcCtD
Epinephrine—Somnolence—Fluorouracil—colon cancer	0.00151	0.0036	CcSEcCtD
Epinephrine—CYP1A2—liver—colon cancer	0.0015	0.00754	CbGeAlD
Epinephrine—Arrhythmia—Capecitabine—colon cancer	0.00149	0.00356	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00147	0.00349	CcSEcCtD
Epinephrine—Mental disorder—Capecitabine—colon cancer	0.00146	0.00349	CcSEcCtD
Epinephrine—CYP3A4—digestive system—colon cancer	0.00146	0.00732	CbGeAlD
Epinephrine—Erythema—Capecitabine—colon cancer	0.00145	0.00346	CcSEcCtD
Epinephrine—CYP2C9—liver—colon cancer	0.00143	0.00715	CbGeAlD
Epinephrine—Drowsiness—Methotrexate—colon cancer	0.00138	0.0033	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—colon cancer	0.00136	0.00324	CcSEcCtD
Epinephrine—ADRA2C—lymph node—colon cancer	0.00133	0.00666	CbGeAlD
Epinephrine—Sweating—Methotrexate—colon cancer	0.00133	0.00316	CcSEcCtD
Epinephrine—Palpitations—Capecitabine—colon cancer	0.00128	0.00306	CcSEcCtD
Epinephrine—SLC22A5—lymph node—colon cancer	0.00127	0.00638	CbGeAlD
Epinephrine—Hypertension—Capecitabine—colon cancer	0.00125	0.00299	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—colon cancer	0.00125	0.00298	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—colon cancer	0.00124	0.00296	CcSEcCtD
Epinephrine—Chest pain—Capecitabine—colon cancer	0.00124	0.00295	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00123	0.00293	CcSEcCtD
Epinephrine—Dizziness—Vincristine—colon cancer	0.0012	0.00287	CcSEcCtD
Epinephrine—Dizziness—Irinotecan—colon cancer	0.00117	0.00279	CcSEcCtD
Epinephrine—Nervous system disorder—Capecitabine—colon cancer	0.00116	0.00277	CcSEcCtD
Epinephrine—Tachycardia—Capecitabine—colon cancer	0.00116	0.00276	CcSEcCtD
Epinephrine—Vomiting—Vincristine—colon cancer	0.00116	0.00276	CcSEcCtD
Epinephrine—Skin disorder—Capecitabine—colon cancer	0.00115	0.00275	CcSEcCtD
Epinephrine—Hyperhidrosis—Capecitabine—colon cancer	0.00115	0.00273	CcSEcCtD
Epinephrine—Vomiting—Irinotecan—colon cancer	0.00113	0.00269	CcSEcCtD
Epinephrine—Dizziness—Fluorouracil—colon cancer	0.00112	0.00268	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—colon cancer	0.00109	0.0026	CcSEcCtD
Epinephrine—CYP3A4—liver—colon cancer	0.00109	0.00545	CbGeAlD
Epinephrine—Erythema—Methotrexate—colon cancer	0.00108	0.00258	CcSEcCtD
Epinephrine—Nausea—Vincristine—colon cancer	0.00108	0.00258	CcSEcCtD
Epinephrine—Vomiting—Fluorouracil—colon cancer	0.00108	0.00257	CcSEcCtD
Epinephrine—Insomnia—Capecitabine—colon cancer	0.00107	0.00256	CcSEcCtD
Epinephrine—Paraesthesia—Capecitabine—colon cancer	0.00106	0.00254	CcSEcCtD
Epinephrine—ADRA2A—lymph node—colon cancer	0.00106	0.00531	CbGeAlD
Epinephrine—Nausea—Irinotecan—colon cancer	0.00105	0.00251	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00102	0.00244	CcSEcCtD
Epinephrine—Nausea—Fluorouracil—colon cancer	0.00101	0.0024	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—colon cancer	0.000921	0.0022	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000915	0.00218	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—colon cancer	0.000866	0.00206	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—colon cancer	0.000857	0.00204	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—colon cancer	0.000853	0.00203	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—colon cancer	0.000798	0.0019	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—colon cancer	0.000793	0.00189	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—colon cancer	0.000785	0.00187	CcSEcCtD
Epinephrine—Dizziness—Capecitabine—colon cancer	0.000784	0.00187	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000762	0.00182	CcSEcCtD
Epinephrine—Vomiting—Capecitabine—colon cancer	0.000754	0.0018	CcSEcCtD
Epinephrine—Nausea—Capecitabine—colon cancer	0.000704	0.00168	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—colon cancer	0.000584	0.00139	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—colon cancer	0.000561	0.00134	CcSEcCtD
Epinephrine—Nausea—Methotrexate—colon cancer	0.000524	0.00125	CcSEcCtD
Epinephrine—ADRB3—Signaling Pathways—MYC—colon cancer	4.37e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—APC—colon cancer	4.36e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—colon cancer	4.36e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—colon cancer	4.36e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—BRAF—colon cancer	4.33e-05	0.000162	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—colon cancer	4.29e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—APC—colon cancer	4.29e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—colon cancer	4.29e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—colon cancer	4.27e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—colon cancer	4.27e-05	0.00016	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—colon cancer	4.25e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—colon cancer	4.2e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGFR3—colon cancer	4.15e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—PIK3CA—colon cancer	4.1e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—BRAF—colon cancer	4.1e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PIK3CA—colon cancer	4.09e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PPARG—colon cancer	4.09e-05	0.000153	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—colon cancer	4.07e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—PIK3CA—colon cancer	4.06e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—KRAS—colon cancer	4.05e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KRAS—colon cancer	4.03e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—BRAF—colon cancer	4.03e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—KRAS—colon cancer	4.02e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—PIK3CA—colon cancer	4.01e-05	0.00015	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—colon cancer	3.99e-05	0.000149	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.99e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—colon cancer	3.97e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—KRAS—colon cancer	3.97e-05	0.000149	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—colon cancer	3.96e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—colon cancer	3.91e-05	0.000146	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.88e-05	0.000145	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGFR3—colon cancer	3.86e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—APC—colon cancer	3.81e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—colon cancer	3.81e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—PIK3CA—colon cancer	3.8e-05	0.000142	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ABCB1—colon cancer	3.79e-05	0.000142	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—colon cancer	3.79e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—colon cancer	3.78e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—colon cancer	3.77e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—KRAS—colon cancer	3.75e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—PIK3CA—colon cancer	3.74e-05	0.00014	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TYMS—colon cancer	3.73e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PIK3CA—colon cancer	3.72e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PIK3CA—colon cancer	3.71e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—KRAS—colon cancer	3.69e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PIK3CA—colon cancer	3.69e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—colon cancer	3.68e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CA—colon cancer	3.64e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—colon cancer	3.64e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—colon cancer	3.59e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—BRAF—colon cancer	3.58e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CCND1—colon cancer	3.55e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—APC—colon cancer	3.54e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—colon cancer	3.54e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CTNNB1—colon cancer	3.51e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—colon cancer	3.47e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CA—colon cancer	3.45e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—colon cancer	3.45e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CDKN1A—colon cancer	3.43e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—colon cancer	3.43e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—colon cancer	3.41e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CA—colon cancer	3.39e-05	0.000127	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—EP300—colon cancer	3.38e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—colon cancer	3.37e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—colon cancer	3.35e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—colon cancer	3.34e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BRAF—colon cancer	3.33e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—colon cancer	3.32e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—colon cancer	3.32e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—colon cancer	3.32e-05	0.000124	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.31e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—EP300—colon cancer	3.29e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—colon cancer	3.29e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—KRAS—colon cancer	3.28e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—colon cancer	3.28e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EP300—colon cancer	3.26e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—colon cancer	3.25e-05	0.000122	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ABCB1—colon cancer	3.24e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CCND1—colon cancer	3.23e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—colon cancer	3.23e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—colon cancer	3.21e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCND1—colon cancer	3.2e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CTNNB1—colon cancer	3.2e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—colon cancer	3.19e-05	0.000119	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TYMS—colon cancer	3.18e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SRC—colon cancer	3.17e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CTNNB1—colon cancer	3.17e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCND1—colon cancer	3.16e-05	0.000118	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—EP300—colon cancer	3.15e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—colon cancer	3.14e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CTNNB1—colon cancer	3.13e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CDKN1A—colon cancer	3.13e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—colon cancer	3.1e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CDKN1A—colon cancer	3.1e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—VEGFA—colon cancer	3.09e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—colon cancer	3.08e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—colon cancer	3.07e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CDKN1A—colon cancer	3.06e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—colon cancer	3.05e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—colon cancer	3.05e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—colon cancer	3.05e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—colon cancer	3.04e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—colon cancer	3.03e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—colon cancer	3.02e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—colon cancer	3.01e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—colon cancer	3.01e-05	0.000113	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCND1—colon cancer	2.99e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—colon cancer	2.98e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EP300—colon cancer	2.97e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CTNNB1—colon cancer	2.96e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EP300—colon cancer	2.95e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCND1—colon cancer	2.94e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CTNNB1—colon cancer	2.91e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EP300—colon cancer	2.91e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CDKN1A—colon cancer	2.89e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SRC—colon cancer	2.89e-05	0.000108	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.87e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SRC—colon cancer	2.87e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CDKN1A—colon cancer	2.85e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—colon cancer	2.84e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—colon cancer	2.84e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SRC—colon cancer	2.83e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—VEGFA—colon cancer	2.82e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—colon cancer	2.82e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—colon cancer	2.8e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—VEGFA—colon cancer	2.79e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—colon cancer	2.79e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—colon cancer	2.78e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—colon cancer	2.78e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—colon cancer	2.77e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—colon cancer	2.76e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—VEGFA—colon cancer	2.76e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EP300—colon cancer	2.75e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—colon cancer	2.72e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	2.71e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EP300—colon cancer	2.71e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—colon cancer	2.69e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SRC—colon cancer	2.68e-05	0.0001	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—EP300—colon cancer	2.67e-05	0.0001	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—colon cancer	2.64e-05	9.89e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SRC—colon cancer	2.63e-05	9.87e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—colon cancer	2.63e-05	9.84e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCND1—colon cancer	2.61e-05	9.79e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—VEGFA—colon cancer	2.61e-05	9.76e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—colon cancer	2.59e-05	9.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—colon cancer	2.59e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	2.59e-05	9.7e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—colon cancer	2.59e-05	9.68e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—colon cancer	2.58e-05	9.64e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—colon cancer	2.57e-05	9.62e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—VEGFA—colon cancer	2.57e-05	9.61e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—colon cancer	2.56e-05	9.59e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—colon cancer	2.54e-05	9.5e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—colon cancer	2.53e-05	9.49e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—colon cancer	2.53e-05	9.49e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	2.53e-05	9.47e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—colon cancer	2.53e-05	9.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	2.52e-05	9.43e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—colon cancer	2.51e-05	9.41e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—colon cancer	2.5e-05	9.38e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCB1—colon cancer	2.5e-05	9.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—colon cancer	2.5e-05	9.35e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—colon cancer	2.48e-05	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—colon cancer	2.46e-05	9.22e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TYMS—colon cancer	2.46e-05	9.21e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.45e-05	9.18e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—colon cancer	2.44e-05	9.12e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCND1—colon cancer	2.43e-05	9.1e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—colon cancer	2.41e-05	9.04e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EP300—colon cancer	2.41e-05	9.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	2.41e-05	9.01e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—colon cancer	2.4e-05	8.98e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—colon cancer	2.39e-05	8.97e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—colon cancer	2.39e-05	8.96e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—colon cancer	2.37e-05	8.89e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—colon cancer	2.36e-05	8.84e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—colon cancer	2.35e-05	8.82e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	2.35e-05	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—colon cancer	2.35e-05	8.79e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—colon cancer	2.34e-05	8.77e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SRC—colon cancer	2.34e-05	8.76e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—colon cancer	2.34e-05	8.75e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—colon cancer	2.33e-05	8.74e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—colon cancer	2.31e-05	8.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—colon cancer	2.29e-05	8.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—VEGFA—colon cancer	2.28e-05	8.54e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—colon cancer	2.26e-05	8.45e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—colon cancer	2.25e-05	8.43e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EP300—colon cancer	2.24e-05	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—colon cancer	2.23e-05	8.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—colon cancer	2.22e-05	8.3e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—colon cancer	2.2e-05	8.24e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—colon cancer	2.18e-05	8.17e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—colon cancer	2.18e-05	8.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SRC—colon cancer	2.17e-05	8.14e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—colon cancer	2.15e-05	8.06e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—colon cancer	2.13e-05	7.97e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VEGFA—colon cancer	2.12e-05	7.93e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—colon cancer	2.11e-05	7.9e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—colon cancer	2.1e-05	7.85e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—colon cancer	2.09e-05	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—colon cancer	2.09e-05	7.83e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—colon cancer	2.08e-05	7.8e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—colon cancer	2.08e-05	7.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—colon cancer	2.05e-05	7.68e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—colon cancer	2.05e-05	7.66e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—colon cancer	2.04e-05	7.63e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—colon cancer	2.04e-05	7.62e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—colon cancer	2.02e-05	7.55e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	2e-05	7.51e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—colon cancer	1.99e-05	7.46e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—colon cancer	1.99e-05	7.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—colon cancer	1.98e-05	7.41e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—colon cancer	1.97e-05	7.39e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—colon cancer	1.97e-05	7.38e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—colon cancer	1.95e-05	7.3e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—colon cancer	1.94e-05	7.28e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—colon cancer	1.94e-05	7.26e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—colon cancer	1.94e-05	7.26e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—colon cancer	1.91e-05	7.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—colon cancer	1.91e-05	7.14e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—colon cancer	1.88e-05	7.06e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—colon cancer	1.85e-05	6.94e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—colon cancer	1.8e-05	6.74e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—colon cancer	1.8e-05	6.73e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—colon cancer	1.78e-05	6.67e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	1.78e-05	6.67e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—colon cancer	1.77e-05	6.65e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—colon cancer	1.76e-05	6.58e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—colon cancer	1.74e-05	6.52e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—EP300—colon cancer	1.73e-05	6.47e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—colon cancer	1.72e-05	6.45e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—colon cancer	1.66e-05	6.23e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	1.65e-05	6.19e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—colon cancer	1.65e-05	6.17e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—colon cancer	1.64e-05	6.13e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—colon cancer	1.62e-05	6.05e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—colon cancer	1.6e-05	5.99e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—colon cancer	1.53e-05	5.73e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—EP300—colon cancer	1.48e-05	5.53e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—colon cancer	1.45e-05	5.45e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—colon cancer	1.37e-05	5.13e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—colon cancer	1.35e-05	5.06e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—colon cancer	1.28e-05	4.79e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—EP300—colon cancer	1.14e-05	4.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.09e-05	4.09e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—colon cancer	1.04e-05	3.91e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—colon cancer	8.92e-06	3.34e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—colon cancer	8.43e-06	3.16e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—colon cancer	6.88e-06	2.58e-05	CbGpPWpGaD
